Skip to content

Inadequate suspension of premixed insulin analogs in Japanese people with type 2 diabetes: Clinical importance of improving injection techniques

Inadequate suspension of premixed insulin analogs in Japanese people with type 2 diabetes: Clinical importance of improving injection techniques - The study of inadequate suspension of premixed insulin analogues

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000022329
Enrollment
500
Registered
2016-06-15
Start date
2016-05-17
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese people wiyh type 2 diabetes receiving premixed insulin analogs therapy

Interventions

None listed

Sponsors

Dokkyo Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Japanese people with type 2 diabetes receiving premixed insulin analogs therapy

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

MeasureTime frame
ODs for the patient's premixed insulin analogs compared to standard insulin curves

Secondary

MeasureTime frame
The differences of ODs compared to standard insulin curves among each of premix insulin analogs

Countries

Japan

Contacts

Public ContactKunihiro Suzuki

Dokkyo Medical University Endocrinology and Metabolism

kuni-s@dokkyomed.ac.jp0282-87-2150

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026